137 related articles for article (PubMed ID: 32390395)
1. LINE-1 Methylation in Chronic HBV Infected Patients: Association with HCC, Gender and MTHFR C677T Polymorphism.
Qiao K; Zhang S; Huo Z; Hou W; Dai Q; Su R; Wang F
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390395
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
[TBL] [Abstract][Full Text] [Related]
3. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
4. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
[TBL] [Abstract][Full Text] [Related]
5. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
7. MTHFR and MTRR gene polymorphisms in patients with chronic hepatitis B virus infections in Zigong, Sichuan Province.
Qiu S; Jin L; Yang D; Zhang D
Ann Hum Biol; 2024 Feb; 51(1):2330926. PubMed ID: 38634541
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
9. A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era.
Badiga S; Johanning GL; Macaluso M; Azuero A; Chambers MM; Siddiqui NR; Piyathilake CJ
PLoS One; 2014; 9(10):e110093. PubMed ID: 25302494
[TBL] [Abstract][Full Text] [Related]
10. Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection.
Karakus N; Yigit S; Kocak M; Bozkurt N; Duygu F
Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):683-695. PubMed ID: 36919686
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
[TBL] [Abstract][Full Text] [Related]
12. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
[TBL] [Abstract][Full Text] [Related]
13. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
[TBL] [Abstract][Full Text] [Related]
14. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
16. Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population.
Al-Shahrani H; Al-Dabbagh N; Al-Dohayan N; Arfin M; Al-Asmari M; Rizvi S; Al-Asmari A
BMC Ophthalmol; 2016 Sep; 16(1):156. PubMed ID: 27585654
[TBL] [Abstract][Full Text] [Related]
17. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes.
Supic G; Jovic N; Kozomara R; Zeljic K; Magic Z
J Dent Res; 2011 Jan; 90(1):65-70. PubMed ID: 20940365
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G polymorphisms influence on leukocyte genomic DNA methylation level.
Weiner AS; Boyarskikh UA; Voronina EN; Mishukova OV; Filipenko ML
Gene; 2014 Jan; 533(1):168-72. PubMed ID: 24103477
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL
Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
